|
1
|
Stahl EC, Haschak MJ, Popovic B and Brown
BN: Macrophages in the aging liver and age-related liver disease.
Front Immunol. 9:27952018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tominaga K and Suzuki HI: TGF-β signaling
in cellular senescence and aging-related pathology. Int J Mol Sci.
20:50022019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Iwaisako K, Brenner DA and Kisseleva T:
What's new in liver fibrosis? The origin of myofibroblasts in liver
fibrosis. J Gastroenterol Hepatol. 27 (Suppl 2):S65–S68. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Aydin MM and Akçalı KC: Liver fibrosis.
Turk J Gastroenterol. 29:14–21. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kim IH, Xu J, Liu X, Koyama Y, Ma HY,
Diggle K, You YH, Schilling JM, Jeste D, Sharma K, et al: Aging
increases the susceptibility of hepatic inflammation, liver
fibrosis and aging in response to high-fat diet in mice. Age
(Dordr). 38:291–302. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Stefanatos R and Sanz A: The role of
mitochondrial ROS in the aging brain. FEBS Lett. 592:743–758. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Davalli P, Mitic T, Caporali A, Lauriola A
and D'Arca D: ROS, cell senescence, and novel molecular mechanisms
in aging and age-related diseases. Oxid Med Cell Longev.
2016:35651272016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kudryavtseva AV, Krasnov GS, Dmitriev AA,
Alekseev BY, Kardymon OL, Sadritdinova AF, Fedorova MS, Pokrovsky
AV, Melnikova NV, Kaprin AD, et al: Mitochondrial dysfunction and
oxidative stress in aging and cancer. Oncotarget. 7:44879–44905.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Luangmonkong T, Suriguga S, Mutsaers HAM,
Groothuis GMM, Olinga P and Boersema M: Targeting oxidative stress
for the treatment of liver fibrosis. Rev Physiol Biochem Pharmacol.
175:71–102. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tao Y, Qiu T, Yao X, Jiang L, Wang N,
Jiang J, Jia X, Wei S, Zhang J, Zhu Y, et al: IRE1α/NOX4 signaling
pathway mediates ROS-dependent activation of hepatic stellate cells
in NaAsO2-induced liver fibrosis. J Cell Physiol.
236:1469–1480. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Valko M, Leibfritz D, Moncol J, Cronin MT,
Mazur M and Telser J: Free radicals and antioxidants in normal
physiological functions and human disease. Int J Biochem Cell Biol.
39:44–84. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ushio-Fukai M: VEGF signaling through
NADPH oxidase-derived ROS. Antioxid Redox Signal. 9:731–739. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ghosh R, Siddharth M, Singh N, Kare PK,
Banerjee BD, Wadhwa N and Tripathi AK: Organochlorine
pesticide-mediated induction of NADPH oxidase and nitric-oxide
synthase in endothelial cell. J Clin Diagn Res. 11:BC09–BC12.
2017.PubMed/NCBI
|
|
14
|
Cheng Q, Li C, Yang CF, Zhong YJ, Wu D,
Shi L, Chen L, Li YW and Li L: Methyl ferulic acid attenuates liver
fibrosis and hepatic stellate cell activation through the
TGF-β1/Smad and NOX4/ROS pathways. Chem Biol Interact. 299:131–139.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen Y, Zhao C, Liu X, Wu G, Zhong J, Zhao
T, Li J, Lin Y, Zhou Y and Wei Y: Plumbagin ameliorates liver
fibrosis via a ROS-mediated NF-κB signaling pathway in vitro and in
vivo. Biomed Pharmacother. 116:1089232019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fougère B, Boulanger E, Nourhashémi F,
Guyonnet S and Cesari M: Chronic inflammation: Accelerator of
biological aging. J Gerontol A Biol Sci Med Sci. 72:1218–1225.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Soysal P, Arik F, Smith L, Jackson SE and
Isik AT: Inflammation, frailty and cardiovascular disease. Adv Exp
Med Biol. 1216:55–64. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Neves J and Sousa-Victor P: Regulation of
inflammation as an anti-aging intervention. FEBS J. 287:43–52.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mangan MSJ, Olhava EJ, Roush WR, Seidel
HM, Glick GD and Latz E: Targeting the NLRP3 inflammasome in
inflammatory diseases. Nat Rev Drug Discov. 17:588–606. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gallego P, Castejón-Vega B, Del Campo JA
and Cordero MD: The absence of NLRP3-inflammasome modulates hepatic
fibrosis progression, lipid metabolism, and inflammation in KO
NLRP3 mice during aging. Cells. 9:21482020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sun L, Ma W, Gao W, Xing Y, Chen L, Xia Z,
Zhang Z and Dai Z: Propofol directly induces caspase-1-dependent
macrophage pyroptosis through the NLRP3-ASC inflammasome. Cell
Death Dis. 10:5422019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Stancu IC, Cremers N, Vanrusselt H,
Couturier J, Vanoosthuyse A, Kessels S, Lodder C, Brône B, Huaux F,
Octave JN, et al: Aggregated tau activates NLRP3-ASC inflammasome
exacerbating exogenously seeded and non-exogenously seeded tau
pathology in vivo. Acta Neuropathol. 137:599–617. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yin Y, Pastrana JL, Li X, Huang X,
Mallilankaraman K, Choi ET, Madesh M, Wang H and Yang XF:
Inflammasomes: Sensors of metabolic stresses for vascular
inflammation. Front Biosci (Landmark Ed). 18:638–649. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Guo H, Callaway JB and Ting JP:
Inflammasomes: Mechanism of action, role in disease, and
therapeutics. Nat Med. 21:677–687. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Malik A and Kanneganti TD: Inflammasome
activation and assembly at a glance. J Cell Sci. 130:3955–3963.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang M, Zhu X, Tong H, Lou A, Li Y, Li Y,
Su L and Li X: AVE 0991 attenuates pyroptosis and liver damage
after heatstroke by inhibiting the ROS-NLRP3 inflammatory
signalling pathway. Biomed Res Int. 2019:18062342019.PubMed/NCBI
|
|
27
|
Baltanás A, Solesio ME, Zalba G, Galindo
MF, Fortuño A and Jordán J: The senescence-accelerated mouse
prone-8 (SAM-P8) oxidative stress is associated with upregulation
of renal NADPH oxidase system. J Physiol Biochem. 69:927–935. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Maroni L, Pinto C, Giordano DM, Saccomanno
S, Banales JM, Spallacci D, Albertini MC, Orlando F, Provinciali M,
Milkiewicz M, et al: Aging-related expression of twinfilin-1
regulates cholangiocyte biological response to injury. Hepatology.
70:883–898. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ye X, Meeker HC, Kozlowski PB, Wegiel J,
Wang KC, Imaki H and Carp RI: Pathological changes in the liver of
a senescence accelerated mouse strain (SAMP8): A mouse model for
the study of liver diseases. Histol Histopathol. 19:1141–1151.
2004.PubMed/NCBI
|
|
30
|
Xiong X, Ren Y, Cui Y, Li R, Wang C and
Zhang Y: Obeticholic acid protects mice against
lipopolysaccharide-induced liver injury and inflammation. Biomed
Pharmacother. 96:1292–1298. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wei X, Chen Y and Huang W: Ginsenoside Rg1
ameliorates liver fibrosis via suppressing epithelial to
mesenchymal transition and reactive oxygen species production in
vitro and in vivo. Biofactors. 44:327–335. 2018. View Article : Google Scholar
|
|
32
|
Kim DH: Chemical diversity of Panax
ginseng, Panax quinquifolium, and Panax notoginseng. J
Ginseng Res. 36:1–15. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Xu TZ, Shen XY, Sun LL, Chen YL, Zhang BQ,
Huang DK and Li WZ: Ginsenoside Rg1 protects against
H2O2-induced neuronal damage due to
inhibition of the NLRP1 inflammasome signalling pathway in
hippocampal neurons in vitro. Int J Mol Med. 43:717–726.
2019.PubMed/NCBI
|
|
34
|
Schmucker DL: Age-related changes in liver
structure and function: Implications for disease ? Exp Gerontol.
40:650–659. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Shen X, Dong X, Han Y, Li Y, Ding S, Zhang
H, Sun Z, Yin Y and Li W and Li W: Ginsenoside Rg1 ameliorates
glomerular fibrosis during kidney aging by inhibiting NOX4 and
NLRP3 inflammasome activation in SAMP8 mice. Int Immunopharmacol.
82:1063392020. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chen Y, Ding S, Zhang H, Sun Z, Shen X,
Sun L, Yin Y, Qun S and Li W: Protective effects of ginsenoside Rg1
on neuronal senescence due to inhibition of NOX2 and NLRP1
inflammasome activation in SAMP8 mice. J Funct Foods.
65:1037132020. View Article : Google Scholar
|
|
37
|
Jones-Bolin S: Guidelines for the care and
use of laboratory animals in biomedical research. Curr Protoc
Pharmacol. 4:4B2012.PubMed/NCBI
|
|
38
|
Wick MR: The hematoxylin and eosin stain
in anatomic pathology-an often-neglected focus of quality assurance
in the laboratory. Semin Diagn Pathol. 36:303–311. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lefkowitch JH: Special stains in
diagnostic liver pathology. Semin Diagn Pathol. 23:190–198. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Iezzoni JC: Diagnostic histochemistry in
hepatic pathology. Semin Diagn Pathol. 35:381–389. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yu H, Zhen J, Yang Y, Gu J, Wu S and Liu
Q: Ginsenoside Rg1 ameliorates diabetic cardiomyopathy by
inhibiting endoplasmic reticulum stress-induced apoptosis in a
streptozotocin-induced diabetes rat model. J Cell Mol Med.
20:623–631. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Liu Q, Zhang FG, Zhang WS, Pan A, Yang YL,
Liu JF, Li P, Liu BL and Qi LW: Ginsenoside Rg1 inhibits
glucagon-induced hepatic gluconeogenesis through Akt-FoxO1
interaction. Theranostics. 7:4001–4012. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Childs BG, Durik M, Baker DJ and van
Deursen JM: Cellular senescence in aging and age-related disease:
From mechanisms to therapy. Nat Med. 21:1424–1435. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kisseleva T and Brenner DA: Mechanisms of
fibrogenesis. Exp Biol Med (Maywood). 233:109–122. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Mo C, Xie S, Zeng T, Lai Y, Huang S, Zhou
C, Yan W, Huang S, Gao L and Lv Z: Ginsenoside-Rg1 acts as an IDO1
inhibitor, protects against liver fibrosis via alleviating
IDO1-mediated the inhibition of DCs maturation. Phytomedicine.
84:1535242021. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Li JP, Gao Y, Chu SF, Zhang Z, Xia CY, Mou
Z, Song XY, He WB, Guo XF and Chen NH: Nrf2 pathway activation
contributes to anti-fibrosis effects of ginsenoside Rg1 in a rat
model of alcohol- and CCl4-induced hepatic fibrosis. Acta Pharmacol
Sin. 35:1031–1044. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Jin CJ, Baumann A, Brandt A, Engstler AJ,
Nier A, Hege M, Schmeer C, Kehm R, Höhn A, Grune T, et al:
Aging-related liver degeneration is associated with increased
bacterial endotoxin and lipopolysaccharide binding protein levels.
Am J Physiol Gastrointest Liver Physiol. 318:G736–G747. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Qin Q, Lin N, Huang H, Zhang X, Cao X,
Wang Y and Li P: Ginsenoside Rg1 ameliorates cardiac oxidative
stress and inflammation in streptozotocin-induced diabetic rats.
Diabetes Metab Syndr Obes. 12:1091–1103. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Dumeus S, Shibu MA, Lin WT, Wang MF, Lai
CH, Shen CY, Lin YM, Viswanadha VP, Kuo WW and Huang CY: Bioactive
peptide improves diet-induced hepatic fat deposition and hepatocyte
proinflammatory response in SAMP8 ageing mice. Cell Physiol
Biochem. 48:1942–1952. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Xu F, Liu C, Zhou D and Zhang L:
TGF-β/SMAD pathway and its regulation in hepatic fibrosis. J
Histochem Cytochem. 64:157–167. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Wang Y, Liu Q, Xu Y, Zhang Y, Lv Y, Tan Y,
Jiang N, Cao G, Ma X, Wang J, et al: Ginsenoside Rg1 protects
against oxidative stress-induced neuronal apoptosis through myosin
IIA-actin related cytoskeletal reorganization. Int J Biol Sci.
12:1341–1356. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Hou L, Sun F, Huang R, Sun W, Zhang D and
Wang Q: Inhibition of NADPH oxidase by apocynin prevents learning
and memory deficits in a mouse Parkinson's disease model. Redox
Biol. 22:1011342019. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Nayernia Z, Jaquet V and Krause KH: New
insights on NOX enzymes in the central nervous system. Antioxid
Redox Signal. 20:2815–2837. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Langley M, Ghosh A, Charli A, Sarkar S, Ay
M, Luo J, Zielonka J, Brenza T, Bennett B, Jin H, et al:
Mito-apocynin prevents mitochondrial dysfunction, microglial
activation, oxidative damage, and progressive neurodegeneration in
MitoPark transgenic mice. Antioxid Redox Signal. 27:1048–1066.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Hsieh CC and Papaconstantinou J:
Thioredoxin-ASK1 complex levels regulate ROS-mediated p38 MAPK
pathway activity in livers of aged and long-lived Snell dwarf mice.
FASEB J. 20:259–268. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Wojtovich AP and Foster TH: Optogenetic
control of ROS production. Redox Biol. 2:368–376. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Huang C, Gan D, Luo F, Wan S, Chen J, Wang
A, Li B and Zhu X: Interaction mechanisms between the NOX4/ROS and
RhoA/ROCK1 signaling pathways as new anti-fibrosis targets of
ursolic acid in hepatic stellate cells. Front Pharmacol.
10:4312019. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Lan T, Kisseleva T and Brenner DA:
Deficiency of NOX1 or NOX4 prevents liver inflammation and fibrosis
in mice through inhibition of hepatic stellate cell activation.
PLoS One. 10:e01297432015. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Gao Y, Chu SF, Zhang Z, Ai QD, Xia CY,
Huang HY and Chen NH: Ginsenoside Rg1 prevents
acetaminophen-induced oxidative stress and apoptosis via Nrf2/ARE
signaling pathway. J Asian Nat Prod Res. 21:782–797. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Koh EJ, Kim KJ, Choi J, Jeon HJ, Seo MJ
and Lee BY: Ginsenoside Rg1 suppresses early stage of adipocyte
development via activation of C/EBP homologous protein-10 in 3T3-L1
and attenuates fat accumulation in high fat diet-induced obese
zebrafish. J Ginseng Res. 41:23–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Fernández-Garcia C, Rancan L, Paredes SD,
Montero C, de la Fuente M, Vara E and Tresguerres JAF: Xanthohumol
exerts protective effects in liver alterations associated with
aging. Eur J Nutr. 58:653–663. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Pinto C, Ninfole E, Benedetti A, Maroni L
and Marzioni M: Aging-related molecular pathways in chronic
cholestatic conditions. Front Med (Lausanne). 6:3322020. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Stakos DA, Stamatelopoulos K, Bampatsias
D, Sachse M, Zormpas E, Vlachogiannis NI, Tual-Chalot S and Stellos
K: The Alzheimer's disease amyloid-beta hypothesis in
cardiovascular aging and disease: JACC focus seminar. J Am Coll
Cardiol. 75:952–967. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Sun X, Nkennor B, Mastikhina O, Soon K and
Nunes SS: Endothelium-mediated contributions to fibrosis. Semin
Cell Dev Biol. 101:78–86. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Zhu H and Li YR: Oxidative stress and
redox signaling mechanisms of inflammatory bowel disease: Updated
experimental and clinical evidence. Exp Biol Med (Maywood).
237:474–480. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Kang R, Li R, Dai P, Li Z, Li Y and Li C:
Deoxynivalenol induced apoptosis and inflammation of IPEC-J2 cells
by promoting ROS production. Environ Pollut. 251:689–698. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Ralston JC, Lyons CL, Kennedy EB, Kirwan
AM and Roche HM: Fatty acids and NLRP3 inflammasome-mediated
inflammation in metabolic tissues. Annu Rev Nutr. 37:77–102. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Elinav E, Strowig T, Kau AL, Henao-Mejia
J, Thaiss CA, Booth CJ, Peaper DR, Bertin J, Eisenbarth SC, Gordon
JI and Flavell RA: NLRP6 inflammasome regulates colonic microbial
ecology and risk for colitis. Cell. 145:745–757. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Song AQ, Gao B, Fan JJ, Zhu YJ, Zhou J,
Wang YL, Xu LZ and Wu WN: NLRP1 inflammasome contributes to chronic
stress-induced depressive-like behaviors in mice. J
Neuroinflammation. 17:1782020. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Yu X, Lan P, Hou X, Han Q, Lu N, Li T,
Jiao C, Zhang J, Zhang C and Tian Z: HBV inhibits LPS-induced NLRP3
inflammasome activation and IL-1β production via suppressing the
NF-κB pathway and ROS production. J Hepatol. 66:693–702. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Cheng YC, Chu LW, Chen JY, Hsieh SL, Chang
YC, Dai ZK and Wu BN: Loganin attenuates high glucose-induced
schwann cells pyroptosis by inhibiting ROS generation and NLRP3
inflammasome activation. Cells. 9:19482020. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Sho T and Xu J: Role and mechanism of ROS
scavengers in alleviating NLRP3-mediated inflammation. Biotechnol
Appl Biochem. 66:4–13. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Wree A, McGeough MD, Inzaugarat ME, Eguchi
A, Schuster S, Johnson CD, Peña CA, Geisler LJ, Papouchado BG,
Hoffman HM and Feldstein AE: NLRP3 inflammasome driven liver injury
and fibrosis: Roles of IL-17 and TNF in mice. Hepatology.
67:736–749. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Mridha AR, Wree A, Robertson AAB, Yeh MM,
Johnson CD, Van Rooyen DM, Haczeyni F, Teoh NC, Savard C, Ioannou
GN, et al: NLRP3 inflammasome blockade reduces liver inflammation
and fibrosis in experimental NASH in mice. J Hepatol. 66:1037–1046.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Cao Z, Fang Y, Lu Y, Tan D, Du C, Li Y, Ma
Q, Yu J, Chen M, Zhou C, et al: Melatonin alleviates
cadmium-induced liver injury by inhibiting the TXNIP-NLRP3
inflammasome. J Pineal Res. 62:e123892017. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Wree A, Eguchi A, McGeough MD, Pena CA,
Johnson CD, Canbay A, Hoffman HM and Feldstein AE: NLRP3
inflammasome activation results in hepatocyte pyroptosis, liver
inflammation, and fibrosis in mice. Hepatology. 59:898–910. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Zhao J, He B, Zhang S, Huang W and Li X:
Ginsenoside Rg1 alleviates acute liver injury through the induction
of autophagy and suppressing NF-κB/NLRP3 inflammasome signaling
pathway. Int J Med Sci. 18:1382–1389. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Cuesta S, Kireev R, Forman K, García C,
Escames G, Ariznavarreta C, Vara E and Tresguerres JA: Melatonin
improves inflammation processes in liver of senescence-accelerated
prone male mice (SAMP8). Exp Gerontol. 45:950–956. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Lawrence T: The nuclear factor NF-kappaB
pathway in inflammation. Cold Spring Harb Perspect Biol.
1:a0016512009. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Dolcet X, Llobet D, Pallares J and
Matias-Guiu X: NF-kB in development and progression of human
cancer. Virchows Arch. 446:475–482. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Zhou D, Huang W, Wei J, Zhang J, Liu Z, Ji
R, Ge S, Xiao M, Fan Y and Lu C: RelB promotes liver fibrosis via
inducing the release of injury-associated inflammatory cytokines. J
Cell Mol Med. 24:6008–6014. 2020. View Article : Google Scholar : PubMed/NCBI
|
